607 related articles for article (PubMed ID: 28114969)
21. Preferential Hematopoietic Differentiation in Induced Pluripotent Stem Cells Derived From Human Umbilical Cord Arterial Endothelial Cells.
Pei H; Li H; Xu L; Zhang B; Zhang H; Jia Y; Liang L; Xie X; Fan Z; Yang Z; Wang X; Song F; He L; Yue W; Pei X
Arterioscler Thromb Vasc Biol; 2023 May; 43(5):697-712. PubMed ID: 36951064
[TBL] [Abstract][Full Text] [Related]
22. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system.
Song B; Fan Y; He W; Zhu D; Niu X; Wang D; Ou Z; Luo M; Sun X
Stem Cells Dev; 2015 May; 24(9):1053-65. PubMed ID: 25517294
[TBL] [Abstract][Full Text] [Related]
23. Reprogramming mechanisms influence the maturation of hematopoietic progenitors from human pluripotent stem cells.
Heo HR; Song H; Kim HR; Lee JE; Chung YG; Kim WJ; Yang SR; Kim KS; Chun T; Lee DR; Hong SH
Cell Death Dis; 2018 Oct; 9(11):1090. PubMed ID: 30356076
[TBL] [Abstract][Full Text] [Related]
24. Tracking of epigenetic changes during hematopoietic differentiation of induced pluripotent stem cells.
Cypris O; Frobel J; Rai S; Franzen J; Sontag S; Goetzke R; Szymanski de Toledo MA; Zenke M; Wagner W
Clin Epigenetics; 2019 Feb; 11(1):19. PubMed ID: 30717806
[TBL] [Abstract][Full Text] [Related]
25. Global epigenetic changes during somatic cell reprogramming to iPS cells.
Mattout A; Biran A; Meshorer E
J Mol Cell Biol; 2011 Dec; 3(6):341-50. PubMed ID: 22044880
[TBL] [Abstract][Full Text] [Related]
26. Reprogramming and differentiation-dependent transcriptional alteration of DNA damage response and apoptosis genes in human induced pluripotent stem cells.
Shimada M; Tsukada K; Kagawa N; Matsumoto Y
J Radiat Res; 2019 Nov; 60(6):719-728. PubMed ID: 31665364
[TBL] [Abstract][Full Text] [Related]
27. The miR-302-Mediated Induction of Pluripotent Stem Cells (iPSC): Multiple Synergistic Reprogramming Mechanisms.
Ying SY; Fang W; Lin SL
Methods Mol Biol; 2018; 1733():283-304. PubMed ID: 29435941
[TBL] [Abstract][Full Text] [Related]
28. Determining epigenetic memory in kidney proximal tubule cell derived induced pluripotent stem cells using a quadruple transgenic reprogrammable mouse.
Khelifi G; Chow T; Whiteley J; Fort V; Humphreys BD; Hussein SMI; Rogers IM
Sci Rep; 2022 Nov; 12(1):20340. PubMed ID: 36434072
[TBL] [Abstract][Full Text] [Related]
29. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells.
Polo JM; Liu S; Figueroa ME; Kulalert W; Eminli S; Tan KY; Apostolou E; Stadtfeld M; Li Y; Shioda T; Natesan S; Wagers AJ; Melnick A; Evans T; Hochedlinger K
Nat Biotechnol; 2010 Aug; 28(8):848-55. PubMed ID: 20644536
[TBL] [Abstract][Full Text] [Related]
30. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
[TBL] [Abstract][Full Text] [Related]
31. Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency.
Muñoz-López A; Romero-Moya D; Prieto C; Ramos-Mejía V; Agraz-Doblas A; Varela I; Buschbeck M; Palau A; Carvajal-Vergara X; Giorgetti A; Ford A; Lako M; Granada I; Ruiz-Xivillé N; Rodríguez-Perales S; Torres-Ruíz R; Stam RW; Fuster JL; Fraga MF; Nakanishi M; Cazzaniga G; Bardini M; Cobo I; Bayon GF; Fernandez AF; Bueno C; Menendez P
Stem Cell Reports; 2016 Oct; 7(4):602-618. PubMed ID: 27666791
[TBL] [Abstract][Full Text] [Related]
32. In vitro generation of HSC-like cells from murine ESCs/iPSCs by enforced expression of LIM-homeobox transcription factor Lhx2.
Kitajima K; Minehata K; Sakimura K; Nakano T; Hara T
Blood; 2011 Apr; 117(14):3748-58. PubMed ID: 21343610
[TBL] [Abstract][Full Text] [Related]
33. Growth factor-activated stem cell circuits and stromal signals cooperatively accelerate non-integrated iPSC reprogramming of human myeloid progenitors.
Park TS; Huo JS; Peters A; Talbot CC; Verma K; Zimmerlin L; Kaplan IM; Zambidis ET
PLoS One; 2012; 7(8):e42838. PubMed ID: 22905176
[TBL] [Abstract][Full Text] [Related]
34. Reactivation of the inactive X chromosome and post-transcriptional reprogramming of Xist in iPSCs.
Kim JS; Choi HW; Araúzo-Bravo MJ; Schöler HR; Do JT
J Cell Sci; 2015 Jan; 128(1):81-7. PubMed ID: 25380819
[TBL] [Abstract][Full Text] [Related]
35. Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells.
Zhao MT; Shao NY; Hu S; Ma N; Srinivasan R; Jahanbani F; Lee J; Zhang SL; Snyder MP; Wu JC
Circ Res; 2017 Nov; 121(11):1237-1250. PubMed ID: 29030344
[TBL] [Abstract][Full Text] [Related]
36. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.
Ye L; Muench MO; Fusaki N; Beyer AI; Wang J; Qi Z; Yu J; Kan YW
Stem Cells Transl Med; 2013 Aug; 2(8):558-66. PubMed ID: 23847002
[TBL] [Abstract][Full Text] [Related]
37. Generation and characterization of integration-free induced pluripotent stem cells from patients with autoimmune disease.
Son MY; Lee MO; Jeon H; Seol B; Kim JH; Chang JS; Cho YS
Exp Mol Med; 2016 May; 48(5):e232. PubMed ID: 27174201
[TBL] [Abstract][Full Text] [Related]
38. JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factors.
Kochat V; Equbal Z; Baligar P; Kumar V; Srivastava M; Mukhopadhyay A
PLoS One; 2017; 12(3):e0173977. PubMed ID: 28328977
[TBL] [Abstract][Full Text] [Related]
39. Retinal Cell Type DNA Methylation and Histone Modifications Predict Reprogramming Efficiency and Retinogenesis in 3D Organoid Cultures.
Wang L; Hiler D; Xu B; AlDiri I; Chen X; Zhou X; Griffiths L; Valentine M; Shirinifard A; Sablauer A; Thiagarajan S; Barabas ME; Zhang J; Johnson D; Frase S; Dyer MA
Cell Rep; 2018 Mar; 22(10):2601-2614. PubMed ID: 29514090
[TBL] [Abstract][Full Text] [Related]
40. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.
Lister R; Pelizzola M; Kida YS; Hawkins RD; Nery JR; Hon G; Antosiewicz-Bourget J; O'Malley R; Castanon R; Klugman S; Downes M; Yu R; Stewart R; Ren B; Thomson JA; Evans RM; Ecker JR
Nature; 2011 Mar; 471(7336):68-73. PubMed ID: 21289626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
